首页 > 最新文献

Archives of Medical Research最新文献

英文 中文
Sex Specific Threshold Effects of Prenatal Stress on Striatal Microglia and Relevant Behaviors in Mice 性别特异性阈值对小鼠纹状体小胶质细胞的影响及相关行为
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-12-20 DOI: 10.1016/j.arcmed.2025.103364
Sara V. Maurer , Maya M. Evans , Mia Dukle , Sreelekha Kundu , Jessica L. Dennis , Rhett M. Ellerbroek , Samantha L. Anema , Venezia C. Roshko , Hanna E. Stevens

Background

Prenatal stress, a neurodevelopmental disorder (NDD) risk factor, induces neurobehavioral alterations, including offspring neuroimmune cells. Variable offspring outcomes may arise from the extent to which prenatal stress crosses “thresholds” for specific effects. Therefore, we sought to determine offspring outcomes using models with different extents of prenatal stress. We focused on striatal outcomes, because of their relevance for NDDs.

Methods

Pregnant CD1 mice were assigned to four groups (each: n = 6): no stress (“NoS”) or stressors administered three times daily: i.p. saline injections (low prenatal stress, LoS), interleukin-6 injections as a component of prenatal stress (immune prenatal stress; ImS), or restraint stress + saline injections (high prenatal stress, HiS), embryonic days 12–18. Behavioral (open field, rotarod, amphetamine-induced stereotypy, water T-maze) and brain and placental immunohistochemical (Iba1, Ki67) assessments of offspring were performed.

Results

In adult offspring, HiS altered behaviors across males and females, while ImS induced fewer behavioral changes, and LoS did not affect behavior. Adult striatal microglia morphologies were mostly unchanged across groups, with only HiS altering striatal density of minimally-ramified cells. However, embryonic striatal microglia were affected by all stressors in distinct ways. The HiS model, and to a lesser extent LoS, also influenced immune components of the maternal-fetal interface: placental macrophages.

Conclusions

High and immune stress affected adult striatal-dependent behavior, exceeding the threshold necessary for persistent impacts mostly in males, but all stress models affected embryonic microglia, suggesting a lower threshold for early neuroimmune impacts. Distinct severities and aspects of prenatal stress may therefore underlie different NDD-relevant outcomes.
产前应激是一种神经发育障碍(NDD)的危险因素,可诱导神经行为改变,包括后代的神经免疫细胞。由于产前压力在多大程度上超过了特定影响的“阈值”,可能会产生不同的后代结果。因此,我们试图用不同程度的产前应激模型来确定后代的结局。我们关注纹状体结果,因为它们与ndd相关。方法将妊娠CD1小鼠分为4组(每组n = 6):无应激组(NoS)或应激源组(每日3次):在胚胎期12-18天内进行生理盐水注射(低产前应激,LoS)、白细胞介素-6注射作为产前应激的组成部分(免疫产前应激,ImS)或约束应激+生理盐水注射(高产前应激,HiS)。对子代进行行为学(开放场地,旋转杆,安非他明诱导的刻板印象,水t迷宫)和脑和胎盘免疫组织化学(Iba1, Ki67)评估。结果在成年后代中,他改变了雄性和雌性的行为,而im引起的行为改变较少,LoS对行为没有影响。各组成体纹状体小胶质细胞形态基本不变,只有最小分枝细胞的纹状体密度发生改变。然而,所有应激源对胚胎纹状体小胶质细胞的影响各不相同。HiS模型和LoS在较小程度上也影响母胎界面的免疫成分:胎盘巨噬细胞。结论高应激和免疫应激影响成年纹状体依赖行为,主要在雄性中超过持续影响所需的阈值,但所有应激模型都影响胚胎小胶质细胞,提示早期神经免疫影响的阈值较低。因此,产前压力的不同严重程度和方面可能是ndd相关结果不同的基础。
{"title":"Sex Specific Threshold Effects of Prenatal Stress on Striatal Microglia and Relevant Behaviors in Mice","authors":"Sara V. Maurer ,&nbsp;Maya M. Evans ,&nbsp;Mia Dukle ,&nbsp;Sreelekha Kundu ,&nbsp;Jessica L. Dennis ,&nbsp;Rhett M. Ellerbroek ,&nbsp;Samantha L. Anema ,&nbsp;Venezia C. Roshko ,&nbsp;Hanna E. Stevens","doi":"10.1016/j.arcmed.2025.103364","DOIUrl":"10.1016/j.arcmed.2025.103364","url":null,"abstract":"<div><h3>Background</h3><div>Prenatal stress, a neurodevelopmental disorder (NDD) risk factor, induces neurobehavioral alterations, including offspring neuroimmune cells. Variable offspring outcomes may arise from the extent to which prenatal stress crosses “thresholds” for specific effects. Therefore, we sought to determine offspring outcomes using models with different extents of prenatal stress. We focused on striatal outcomes, because of their relevance for NDDs.</div></div><div><h3>Methods</h3><div>Pregnant CD1 mice were assigned to four groups (each: n = 6): no stress (“NoS”) or stressors administered three times daily: i.p. saline injections (low prenatal stress, LoS), interleukin-6 injections as a component of prenatal stress (immune prenatal stress; ImS), or restraint stress + saline injections (high prenatal stress, HiS), embryonic days 12–18. Behavioral (open field, rotarod, amphetamine-induced stereotypy, water T-maze) and brain and placental immunohistochemical (Iba1, Ki67) assessments of offspring were performed.</div></div><div><h3>Results</h3><div>In adult offspring, HiS altered behaviors across males and females, while ImS induced fewer behavioral changes, and LoS did not affect behavior. Adult striatal microglia morphologies were mostly unchanged across groups, with only HiS altering striatal density of minimally-ramified cells. However, embryonic striatal microglia were affected by all stressors in distinct ways. The HiS model, and to a lesser extent LoS, also influenced immune components of the maternal-fetal interface: placental macrophages.</div></div><div><h3>Conclusions</h3><div>High and immune stress affected adult striatal-dependent behavior, exceeding the threshold necessary for persistent impacts mostly in males, but all stress models affected embryonic microglia, suggesting a lower threshold for early neuroimmune impacts. Distinct severities and aspects of prenatal stress may therefore underlie different NDD-relevant outcomes.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103364"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of High-Altitude Reference Values for the Pan-Immune-Inflammation Value in Healthy Adults Living in Mexico City 墨西哥城健康成人泛免疫炎症值高海拔参考值的建立
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-08-20 DOI: 10.1016/j.arcmed.2025.103281
Luis M Amezcua-Guerra , Malinalli Brianza-Padilla , Mireya Martínez-García , Guadalupe Gutiérrez-Esparza

Background

The Pan-Immune-Inflammation Value (PIV) is a novel composite biomarker that combines neutrophil, monocyte, platelet, and lymphocyte counts. It is useful for prognostic stratification across various clinical conditions. However, reference values for PIV have predominantly been established in populations living below 1000 m, which limits its applicability in high-altitude regions.

Aim

To establish reference values for PIV and its hematological components in healthy adults living in Mexico City.

Methods

Data from the Tlalpan 2020 cohort, a prospective study of healthy adults aged 20–50 from Mexico City, were analyzed. Reference values were determined following the Clinical and Laboratory Standards Institute guidelines, with stratification by sex.

Results

A total of 2290 participants (63% women) with a mean age of 37.0 ± 9.1 years were included. The mean PIV was 249.6 ± 416.9, which decreased to 221.9 ± 332.2 after excluding outliers. Significant sex differences were observed, with women exhibiting higher PIV values. The reference ranges for the total cohort were 65.8–491.6, with sex-specific ranges of 66.7–519.1 for women and 62.8–441.3 for men. Women also had higher reference values for neutrophils and platelets, while monocytes and lymphocytes were similar between sexes.

Conclusions

This study provides high-altitude-specific reference values for PIV and its components in Mexico City’s population, which are notably lower than those in low-altitude regions. The observed sex differences highlight the importance of considering sex as a biological variable when interpreting immunoinflammatory biomarkers.
泛免疫炎症值(PIV)是一种结合中性粒细胞、单核细胞、血小板和淋巴细胞计数的新型复合生物标志物。它对不同临床状况的预后分层是有用的。然而,PIV的参考值主要是在1000米以下的人群中建立的,这限制了其在高海拔地区的适用性。目的建立墨西哥城健康成人PIV及其血液学指标的参考值。方法分析来自Tlalpan 2020队列的数据,这是一项来自墨西哥城的20-50岁健康成年人的前瞻性研究。参考值是根据临床和实验室标准协会的指南确定的,并按性别分层。结果共纳入2290例受试者,其中女性63%,平均年龄37.0±9.1岁。平均PIV为249.6±416.9,剔除异常值后降至221.9±332.2。观察到显著的性别差异,女性表现出更高的PIV值。整个队列的参考范围为65.8-491.6,女性为66.7-519.1,男性为62.8-441.3。女性中性粒细胞和血小板的参考值也更高,而单核细胞和淋巴细胞的参考值在两性之间相似。结论本研究提供了墨西哥城人口PIV及其成分的高海拔特异性参考值,该参考值明显低于低海拔地区。观察到的性别差异强调了在解释免疫炎症生物标志物时将性别作为生物学变量考虑的重要性。
{"title":"Establishment of High-Altitude Reference Values for the Pan-Immune-Inflammation Value in Healthy Adults Living in Mexico City","authors":"Luis M Amezcua-Guerra ,&nbsp;Malinalli Brianza-Padilla ,&nbsp;Mireya Martínez-García ,&nbsp;Guadalupe Gutiérrez-Esparza","doi":"10.1016/j.arcmed.2025.103281","DOIUrl":"10.1016/j.arcmed.2025.103281","url":null,"abstract":"<div><h3>Background</h3><div>The Pan-Immune-Inflammation Value (PIV) is a novel composite biomarker that combines neutrophil, monocyte, platelet, and lymphocyte counts. It is useful for prognostic stratification across various clinical conditions. However, reference values for PIV have predominantly been established in populations living below 1000 m, which limits its applicability in high-altitude regions.</div></div><div><h3>Aim</h3><div>To establish reference values for PIV and its hematological components in healthy adults living in Mexico City.</div></div><div><h3>Methods</h3><div>Data from the Tlalpan 2020 cohort, a prospective study of healthy adults aged 20–50 from Mexico City, were analyzed. Reference values were determined following the Clinical and Laboratory Standards Institute guidelines, with stratification by sex.</div></div><div><h3>Results</h3><div>A total of 2290 participants (63% women) with a mean age of 37.0 ± 9.1 years were included. The mean PIV was 249.6 ± 416.9, which decreased to 221.9 ± 332.2 after excluding outliers. Significant sex differences were observed, with women exhibiting higher PIV values. The reference ranges for the total cohort were 65.8–491.6, with sex-specific ranges of 66.7–519.1 for women and 62.8–441.3 for men. Women also had higher reference values for neutrophils and platelets, while monocytes and lymphocytes were similar between sexes.</div></div><div><h3>Conclusions</h3><div>This study provides high-altitude-specific reference values for PIV and its components in Mexico City’s population, which are notably lower than those in low-altitude regions. The observed sex differences highlight the importance of considering sex as a biological variable when interpreting immunoinflammatory biomarkers.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103281"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical considerations in the use of add-ons in assisted reproductive technologies 辅助生殖技术中使用附加组件的伦理考虑
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-08-25 DOI: 10.1016/j.arcmed.2025.103287
Rocío Núñez Calonge , Rafael Trinchant , Josep Santaló , Fernando Abellán , Lydia Feito , Alfonso De La Fuente , Javier Marqueta , Montserrat Roca , Marina Martinez , Elisa Salo , Ignacio Arnott , Víctor Saul Vital Reyes
{"title":"Ethical considerations in the use of add-ons in assisted reproductive technologies","authors":"Rocío Núñez Calonge ,&nbsp;Rafael Trinchant ,&nbsp;Josep Santaló ,&nbsp;Fernando Abellán ,&nbsp;Lydia Feito ,&nbsp;Alfonso De La Fuente ,&nbsp;Javier Marqueta ,&nbsp;Montserrat Roca ,&nbsp;Marina Martinez ,&nbsp;Elisa Salo ,&nbsp;Ignacio Arnott ,&nbsp;Víctor Saul Vital Reyes","doi":"10.1016/j.arcmed.2025.103287","DOIUrl":"10.1016/j.arcmed.2025.103287","url":null,"abstract":"","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103287"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144902338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis 单羧酸转运蛋白4抑制可减少类风湿关节炎缺氧下滑膜增生和代谢重编程
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-08-18 DOI: 10.1016/j.arcmed.2025.103283
Meican Ma, Ting Liu, Haifeng Chen, Zhao Wang, Jie Zhou, Yu Zhou, Fenghong Yuan

Objectives

In hypoxic conditions, the acidic environment characteristic of rheumatoid arthritis (RA) induces metabolic changes in fibroblast-like synoviocytes (FLS), markedly promoting the synovial proliferation. Monocarboxylate transporter 4 (MCT4) plays a crucial role in cellular pH regulation and synovial fibroblast activation by regulating lactate export. This study investigates the impact of MCT4 inhibition on RA and elucidates its underlying mechanisms.

Method

RA-FLS cells were treated with siMCT4 and VB124 (a selective MCT4 inhibitor), significantly affecting glucose and glutamine uptake and altering lactate efflux. Metabolite analysis using liquid chromatography-mass spectrometry (LC-MS) revealed the mechanisms of carbon metabolism reprogramming. ChIP-qPCR analysis demonstrated changes in hypoxia-inducible factor-1α (HIF1-α) binding to the MCT4 promoter. The therapeutic effects of siMCT4 and VB124 were validated in a collagen-induced arthritis (CIA) model, and their efficacy was assessed through arthritis scores and histological examination.

Results

In patients with RA, MCT4 levels are significantly elevated. Inhibition of MCT4 effectively reduces synovial hyperproliferation and impacts metabolic reprogramming. Specifically, blocking MCT4 in RA-FLS reduces glucose consumption and lactate production while remodeling the metabolic landscape by increasing fumarate, citrate, and malate levels, and decreasing glucose-6-phosphate and aspartate levels. This metabolic shift is accompanied by improvements in mitochondrial structure and function, reduced mitochondrial swelling, and decreased oxidative stress, underscoring the relationship between MCT4 inhibition and cellular energetics. Furthermore, our investigations reveal that HIF1-α directly regulates MCT4 activation, providing a molecular mechanism by which hypoxia promotes MCT4-mediated metabolic reprogramming.

Conclusion

These findings highlight MCT4 as a central regulator of RA proliferation and a promising therapeutic target.
目的:在缺氧条件下,类风湿关节炎(RA)的酸性环境特征诱导成纤维细胞样滑膜细胞(FLS)代谢变化,显著促进滑膜增殖。单羧酸转运蛋白4 (MCT4)通过调节乳酸输出在细胞pH调节和滑膜成纤维细胞活化中起关键作用。本研究探讨MCT4抑制对RA的影响,并阐明其潜在机制。方法用siMCT4和VB124(一种选择性MCT4抑制剂)处理ra - fls细胞,显著影响葡萄糖和谷氨酰胺摄取并改变乳酸外排。液相色谱-质谱联用分析揭示了碳代谢重编程的机制。ChIP-qPCR分析显示缺氧诱导因子-1α (HIF1-α)与MCT4启动子结合的变化。在胶原诱导关节炎(CIA)模型中验证siMCT4和VB124的治疗效果,并通过关节炎评分和组织学检查评估其疗效。结果RA患者MCT4水平明显升高。抑制MCT4有效地减少滑膜过度增生和影响代谢重编程。具体而言,在RA-FLS中阻断MCT4可减少葡萄糖消耗和乳酸生成,同时通过增加富马酸盐、柠檬酸盐和苹果酸盐水平以及降低葡萄糖-6-磷酸和天冬氨酸水平重塑代谢景观。这种代谢转变伴随着线粒体结构和功能的改善、线粒体肿胀的减少和氧化应激的降低,强调了MCT4抑制与细胞能量学之间的关系。此外,我们的研究表明,HIF1-α直接调节MCT4的激活,提供了缺氧促进MCT4介导的代谢重编程的分子机制。结论这些发现表明MCT4是RA增殖的中心调节因子,是一个有希望的治疗靶点。
{"title":"Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis","authors":"Meican Ma,&nbsp;Ting Liu,&nbsp;Haifeng Chen,&nbsp;Zhao Wang,&nbsp;Jie Zhou,&nbsp;Yu Zhou,&nbsp;Fenghong Yuan","doi":"10.1016/j.arcmed.2025.103283","DOIUrl":"10.1016/j.arcmed.2025.103283","url":null,"abstract":"<div><h3>Objectives</h3><div>In hypoxic conditions, the acidic environment characteristic of rheumatoid arthritis (RA) induces metabolic changes in fibroblast-like synoviocytes (FLS), markedly promoting the synovial proliferation. Monocarboxylate transporter 4 (MCT4) plays a crucial role in cellular pH regulation and synovial fibroblast activation by regulating lactate export. This study investigates the impact of MCT4 inhibition on RA and elucidates its underlying mechanisms.</div></div><div><h3>Method</h3><div>RA-FLS cells were treated with siMCT4 and VB124 (a selective MCT4 inhibitor), significantly affecting glucose and glutamine uptake and altering lactate efflux. Metabolite analysis using liquid chromatography-mass spectrometry (LC-MS) revealed the mechanisms of carbon metabolism reprogramming. ChIP-qPCR analysis demonstrated changes in hypoxia-inducible factor-1α (HIF1-α) binding to the MCT4 promoter. The therapeutic effects of siMCT4 and VB124 were validated in a collagen-induced arthritis (CIA) model, and their efficacy was assessed through arthritis scores and histological examination.</div></div><div><h3>Results</h3><div>In patients with RA, MCT4 levels are significantly elevated. Inhibition of MCT4 effectively reduces synovial hyperproliferation and impacts metabolic reprogramming. Specifically, blocking MCT4 in RA-FLS reduces glucose consumption and lactate production while remodeling the metabolic landscape by increasing fumarate, citrate, and malate levels, and decreasing glucose-6-phosphate and aspartate levels. This metabolic shift is accompanied by improvements in mitochondrial structure and function, reduced mitochondrial swelling, and decreased oxidative stress, underscoring the relationship between MCT4 inhibition and cellular energetics. Furthermore, our investigations reveal that HIF1-α directly regulates MCT4 activation, providing a molecular mechanism by which hypoxia promotes MCT4-mediated metabolic reprogramming.</div></div><div><h3>Conclusion</h3><div>These findings highlight MCT4 as a central regulator of RA proliferation and a promising therapeutic target.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103283"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program 揭示2型糖尿病纵向体重动态:来自综合护理计划的见解
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-08-20 DOI: 10.1016/j.arcmed.2025.103271
Ana C. García-Ulloa , Liliana Pérez-Peralta , Luz E. Urbina-Arronte , José L. Cárdenas-Fragoso , Maria V. Landa-Anell , Marco A. Melgarejo-Hernández , Valeria Miranda Gil , Sergio Ponce-de-León , Sergio Hernández-Jiménez , Group of Study CAIPaDi

Background and Aims

Overweight and obesity are prevalent conditions that contribute to significant health problems, including type two diabetes (T2D). Moderate weight loss improves metabolic control and cardiovascular risk. We aimed to identify the demographic and clinical characteristics of patients with T2D who experienced weight changes after a multidisciplinary intervention.

Methods

We analyzed 622 patients with complete 3-year follow-up information. Inclusion criteria were less than 5-years since diabetes diagnosis and an absence of disabling chronic complications. Descriptive statistics, ANOVA or Kruskal-Wallis tests were used for group comparisons, and logistic regression to identify predictors of weight change.

Results

Participants were 56.2 % women, with an average age of 55.8 ± 10.5 years. 53 % were overweight and 47 % were obese at baseline. At 3-years, 35.5 % lost weight, 33.9 % maintained weight, and 30.5 % gained weight; 16.6 % achieved a normal weight. Patients who gained weight were younger than those who lost or maintained it (60 vs. 61 years, p = 0.04). Higher baseline HbA1c (OR 1.14, 95 % CI 1.03–1.26, p = 0.008) and lower quality of life at three months (OR 1.48, 95 % CI 0.95–2.28, p = 0.07) were associated with weight gain. Higher baseline BMI (OR 0.90, 95 % CI 0.85–0.95, p < 0.001), longer diabetes duration (OR 0.81, 95 % CI 0.70–0.94, p = 0.005), and iSGLT2 treatment were linked to weight loss.

Conclusion

Only 16 % of patients achieved normal weight after 3-years: 35.5 % lost weight, 33.9 % maintained their weight, and 30.5 % gained weight. Identifying predictors of weight change may guide targeted interventions in diabetes care.
背景和目的超重和肥胖是导致包括2型糖尿病(T2D)在内的重大健康问题的普遍状况。适度减肥可以改善代谢控制和心血管风险。我们的目的是确定在多学科干预后经历体重变化的T2D患者的人口学和临床特征。方法对622例患者进行完整的3年随访资料分析。纳入标准为糖尿病诊断后不到5年,无致残性慢性并发症。描述性统计、方差分析或Kruskal-Wallis检验用于组间比较,logistic回归用于确定体重变化的预测因子。结果女性占56.2%,平均年龄(55.8±10.5)岁。53%的人超重,47%的人肥胖。3年后,35.5%的人体重减轻,33.9%的人保持体重,30.5%的人体重增加;16.6%达到正常体重。体重增加的患者比体重减轻或保持不变的患者更年轻(60岁对61岁,p = 0.04)。较高的基线HbA1c (OR 1.14, 95% CI 1.03-1.26, p = 0.008)和较低的3个月生活质量(OR 1.48, 95% CI 0.95-2.28, p = 0.07)与体重增加有关。较高的基线BMI (OR 0.90, 95% CI 0.85-0.95, p < 0.001)、较长的糖尿病病程(OR 0.81, 95% CI 0.70-0.94, p = 0.005)和iSGLT2治疗与体重减轻有关。结论3年后只有16%的患者体重恢复正常,35.5%的患者体重减轻,33.9%的患者体重保持不变,30.5%的患者体重增加。确定体重变化的预测因素可以指导有针对性的糖尿病治疗干预。
{"title":"Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program","authors":"Ana C. García-Ulloa ,&nbsp;Liliana Pérez-Peralta ,&nbsp;Luz E. Urbina-Arronte ,&nbsp;José L. Cárdenas-Fragoso ,&nbsp;Maria V. Landa-Anell ,&nbsp;Marco A. Melgarejo-Hernández ,&nbsp;Valeria Miranda Gil ,&nbsp;Sergio Ponce-de-León ,&nbsp;Sergio Hernández-Jiménez ,&nbsp;Group of Study CAIPaDi","doi":"10.1016/j.arcmed.2025.103271","DOIUrl":"10.1016/j.arcmed.2025.103271","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Overweight and obesity are prevalent conditions that contribute to significant health problems, including type two diabetes (T2D). Moderate weight loss improves metabolic control and cardiovascular risk. We aimed to identify the demographic and clinical characteristics of patients with T2D who experienced weight changes after a multidisciplinary intervention.</div></div><div><h3>Methods</h3><div>We analyzed 622 patients with complete 3-year follow-up information. Inclusion criteria were less than 5-years since diabetes diagnosis and an absence of disabling chronic complications. Descriptive statistics, ANOVA or Kruskal-Wallis tests were used for group comparisons, and logistic regression to identify predictors of weight change.</div></div><div><h3>Results</h3><div>Participants were 56.2 % women, with an average age of 55.8 ± 10.5 years. 53 % were overweight and 47 % were obese at baseline. At 3-years, 35.5 % lost weight, 33.9 % maintained weight, and 30.5 % gained weight; 16.6 % achieved a normal weight. Patients who gained weight were younger than those who lost or maintained it (60 vs. 61 years, <em>p</em> = 0.04). Higher baseline HbA1c (OR 1.14, 95 % CI 1.03–1.26, <em>p</em> = 0.008) and lower quality of life at three months (OR 1.48, 95 % CI 0.95–2.28, <em>p</em> = 0.07) were associated with weight gain. Higher baseline BMI (OR 0.90, 95 % CI 0.85–0.95, <em>p</em> &lt; 0.001), longer diabetes duration (OR 0.81, 95 % CI 0.70–0.94, <em>p</em> = 0.005), and iSGLT2 treatment were linked to weight loss.</div></div><div><h3>Conclusion</h3><div>Only 16 % of patients achieved normal weight after 3-years: 35.5 % lost weight, 33.9 % maintained their weight, and 30.5 % gained weight. Identifying predictors of weight change may guide targeted interventions in diabetes care.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103271"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewers list 评论家列表
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2026-01-28 DOI: 10.1016/S0188-4409(25)00189-4
{"title":"Reviewers list","authors":"","doi":"10.1016/S0188-4409(25)00189-4","DOIUrl":"10.1016/S0188-4409(25)00189-4","url":null,"abstract":"","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103371"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146074090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uterus Transplantation: State of the Art in and Arrent Status in Mexico 子宫移植:墨西哥的技术现状和现状
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-09-07 DOI: 10.1016/j.arcmed.2025.103280
Luis Eduardo Magdaleno-Marquez , Sonny John Stetson , Aldo Loza Mapomé , Julio César Del Hierro Yepo , Juan Carlos Cantón Romero , Edwin Ramirez , Federico Mendoza Sánchez , Diego Federico Mendoza Medina , Roberto Enrique Díaz González , Martha Isolina García Amador , Luis Arturo Ruvalcaba-Castellon
This study examines uterine transplantation (UTx) in 2024. It focuses on various aspects, such as animal models, clinical outcomes, surgical procedures, patient perspectives, and ethical and legal considerations. The study particularly considers the context of Mexico. We also explore collaborative initiatives and the public health implications of this innovative reproductive advancement technology.
本研究探讨子宫移植(UTx)在2024年。它侧重于各个方面,如动物模型,临床结果,外科手术,病人的观点,以及伦理和法律方面的考虑。这项研究特别考虑了墨西哥的背景。我们还探讨了这种创新的生殖进步技术的合作倡议和公共卫生影响。
{"title":"Uterus Transplantation: State of the Art in and Arrent Status in Mexico","authors":"Luis Eduardo Magdaleno-Marquez ,&nbsp;Sonny John Stetson ,&nbsp;Aldo Loza Mapomé ,&nbsp;Julio César Del Hierro Yepo ,&nbsp;Juan Carlos Cantón Romero ,&nbsp;Edwin Ramirez ,&nbsp;Federico Mendoza Sánchez ,&nbsp;Diego Federico Mendoza Medina ,&nbsp;Roberto Enrique Díaz González ,&nbsp;Martha Isolina García Amador ,&nbsp;Luis Arturo Ruvalcaba-Castellon","doi":"10.1016/j.arcmed.2025.103280","DOIUrl":"10.1016/j.arcmed.2025.103280","url":null,"abstract":"<div><div>This study examines uterine transplantation (UTx) in 2024. It focuses on various aspects, such as animal models, clinical outcomes, surgical procedures, patient perspectives, and ethical and legal considerations. The study particularly considers the context of Mexico. We also explore collaborative initiatives and the public health implications of this innovative reproductive advancement technology.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103280"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145010565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Primer on Monkeypox Infection: An Emerging Threat to Global Public Health 猴痘感染入门:对全球公共卫生的新威胁
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-08-20 DOI: 10.1016/j.arcmed.2025.103279
Rasanpreet Kaur , Saurabh Gupta , Shreya Pathak , Manish Sharma , Deepak Parashar , Bhuvnesh Prasad Sharma , Vivek Kashyap , Jitendra Singh , Chakresh Jain , Prem Shankar
Monkeypox (mpox) is caused by a poxvirus closely related to the smallpox virus. It spreads by intimate contact between humans and animals. Prior immunization against smallpox only provides partial protection against mpox. Recently, the WHO declared mpox as a global public health emergency. Mpox is characterized by a brief febrile illness with lymphadenopathy, followed by a rash that develops in phases of macules, papules, vesicles, and pustules, spreading centrifugally. Most patients recover within two to four weeks. Children, pregnant women, and immunocompromised individuals are more likely to experience complications. A precise laboratory diagnosis can be made by using a molecular method, such as polymerase chain reaction (PCR) to detect viral DNA in the tested sample. Most of the treatment is symptomatic, and supportive care is usually sufficient for moderate, self-limited cases of mpox. However, antiviral medications, such as tecovirimat, brincidofovir, and cidofovir, as well as vaccinia immune globulin intravenous (VIGIV), are available as therapeutic options. For high-risk groups, such as healthcare professionals and close contacts, vaccination with currently available smallpox vaccines is advised. This review emphasizes an overview of the history, etiology, epidemiology, structure, reservoirs, transmission, virus phylogeny, genome organization, clinical cases and symptoms, diagnosis, treatment, and prevention of mpox with recent updates. Therefore, a multifaceted approach is essential and includes improved surveillance, early diagnosis, isolation of index cases, immunization, and adoption of a “One Health” approach to prevent an mpox outbreak.
猴痘是由一种与天花病毒密切相关的痘病毒引起的。它通过人与动物的亲密接触传播。事先接种天花疫苗只能提供部分预防m痘的保护。最近,世界卫生组织宣布麻疹为全球突发公共卫生事件。麻疹的特点是短暂的发热性疾病,伴有淋巴结病变,随后出现分阶段的皮疹,有斑疹、丘疹、囊泡和脓疱,呈离心扩散。大多数患者在两到四周内康复。儿童、孕妇和免疫功能低下的人更容易出现并发症。精确的实验室诊断可以通过使用分子方法,如聚合酶链反应(PCR)来检测检测样本中的病毒DNA。大多数治疗是对症的,支持性护理通常对中度、自限性m痘病例就足够了。然而,抗病毒药物,如替科维莫、brincidofovir和西多福韦,以及牛痘免疫球蛋白静脉注射(VIGIV),都是可用的治疗选择。对于高危人群,如卫生保健专业人员和密切接触者,建议接种目前可用的天花疫苗。本文综述了麻疹的历史、病因学、流行病学、结构、宿主、传播、病毒系统发育、基因组组织、临床病例和症状、诊断、治疗和预防的最新进展。因此,必须采取多方面的方法,包括改进监测、早期诊断、隔离指示病例、免疫接种和采用“同一个健康”方法来预防痘暴发。
{"title":"A Primer on Monkeypox Infection: An Emerging Threat to Global Public Health","authors":"Rasanpreet Kaur ,&nbsp;Saurabh Gupta ,&nbsp;Shreya Pathak ,&nbsp;Manish Sharma ,&nbsp;Deepak Parashar ,&nbsp;Bhuvnesh Prasad Sharma ,&nbsp;Vivek Kashyap ,&nbsp;Jitendra Singh ,&nbsp;Chakresh Jain ,&nbsp;Prem Shankar","doi":"10.1016/j.arcmed.2025.103279","DOIUrl":"10.1016/j.arcmed.2025.103279","url":null,"abstract":"<div><div>Monkeypox (mpox) is caused by a poxvirus closely related to the smallpox virus. It spreads by intimate contact between humans and animals. Prior immunization against smallpox only provides partial protection against mpox. Recently, the WHO declared mpox as a global public health emergency. Mpox is characterized by a brief febrile illness with lymphadenopathy, followed by a rash that develops in phases of macules, papules, vesicles, and pustules, spreading centrifugally. Most patients recover within two to four weeks. Children, pregnant women, and immunocompromised individuals are more likely to experience complications. A precise laboratory diagnosis can be made by using a molecular method, such as polymerase chain reaction (PCR) to detect viral DNA in the tested sample. Most of the treatment is symptomatic, and supportive care is usually sufficient for moderate, self-limited cases of mpox. However, antiviral medications, such as tecovirimat, brincidofovir, and cidofovir, as well as vaccinia immune globulin intravenous (VIGIV), are available as therapeutic options. For high-risk groups, such as healthcare professionals and close contacts, vaccination with currently available smallpox vaccines is advised. This review emphasizes an overview of the history, etiology, epidemiology, structure, reservoirs, transmission, virus phylogeny, genome organization, clinical cases and symptoms, diagnosis, treatment, and prevention of mpox with recent updates. Therefore, a multifaceted approach is essential and includes improved surveillance, early diagnosis, isolation of index cases, immunization, and adoption of a “One Health” approach to prevent an mpox outbreak.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103279"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Adipose Tissue Depots in Immediate versus Delayed Breast Reconstruction 即时与延迟乳房重建脂肪组织库的比较分析。
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-12-23 DOI: 10.1016/j.arcmed.2025.103360
Carlos Pinho , Beatriz Soares , Beatriz Costa , Diogo Teixeira , Maria J. Salazar , Fani L. Neto , Henrique Almeida , António Costa-Ferreira , Adriana R. Rodrigues , Alexandra M. Gouveia

Background

Mastectomy followed by breast reconstruction is the standard treatment for breast cancer. Choosing autologous tissue requires an in-depth understanding of the molecular and structural characteristics of the different adipose tissue depots.

Method

White adipose tissue (WAT) from five different locations (above and below the abdominal Scarpa’s fascia, thighs, breast skin envelope, and omentum) was collected from 24 patients undergoing breast reconstruction and grouped based on immediate (IBR) or delayed (DBR) reconstruction. The adipocyte area was analyzed in histologically processed WAT sections. Transcription and protein expression profiles, related to inflammation, fibrosis, browning, and adipose-derived stem cells (ADSCs) content were determined by RT-qPCR and Western blotting.

Results

Compared to IBR, omental WAT from DBR patients exhibits larger adipocytes, and higher expression of TIMP1, FN1, CD206, and CD45, as well as lower levels of CIDEA. Breast fat also differs between the two groups, with lower levels of IL6 and CIDEA, and overexpression of FN1 in the DBR group. Within the IBR group, breast fat shows higher levels of IL6, TIMP1 and CIDEA, but lower expression of FN1 and COL3A1 than subcutaneous WAT.

Conclusion

Omental fat in the IBR cohort has properties similar to those of subcutaneous WAT, indicating that the omentum is a promising candidate for rapid breast restoration. In the DBR group, the omentum molecular signature suggests a change towards a pro-fibrotic phenotype and a reduced remodeling capacity, suggesting that it should not be the primary choice for breast reconstruction. This study emphasizes the importance of careful WAT selection to minimize adverse outcomes, including cancer recurrence, and underscores the diverse physiology of fat depots.
背景:乳房切除术后乳房重建是乳腺癌的标准治疗方法。选择自体组织需要深入了解不同脂肪组织库的分子和结构特征。方法:选取24例乳房再造术患者的5个不同部位(腹部斯卡帕筋膜上下、大腿、乳房皮肤包膜、大网膜)的白色脂肪组织(WAT),按即刻(IBR)或延迟(DBR)再造术分组。在组织学处理的WAT切片上分析脂肪细胞面积。通过RT-qPCR和Western blotting检测与炎症、纤维化、褐变和脂肪源性干细胞(ADSCs)含量相关的转录和蛋白质表达谱。结果:与IBR相比,DBR患者网膜WAT表现出更大的脂肪细胞,TIMP1、FN1、CD206和CD45的表达更高,而CIDEA的表达水平更低。两组之间的乳腺脂肪也不同,DBR组的il - 6和CIDEA水平较低,FN1过表达。与皮下WAT相比,IBR组乳腺脂肪中IL6、TIMP1和CIDEA水平较高,而FN1和COL3A1表达较低。结论:IBR患者的大网膜脂肪具有与皮下WAT相似的特性,表明大网膜是快速乳房修复的有希望的候选者。在DBR组中,大网膜分子特征提示促纤维化表型的改变和重塑能力的降低,这表明它不应该是乳房重建的首选。本研究强调了谨慎选择WAT以减少不良后果(包括癌症复发)的重要性,并强调了脂肪库的多种生理特征。
{"title":"Comparative Analysis of Adipose Tissue Depots in Immediate versus Delayed Breast Reconstruction","authors":"Carlos Pinho ,&nbsp;Beatriz Soares ,&nbsp;Beatriz Costa ,&nbsp;Diogo Teixeira ,&nbsp;Maria J. Salazar ,&nbsp;Fani L. Neto ,&nbsp;Henrique Almeida ,&nbsp;António Costa-Ferreira ,&nbsp;Adriana R. Rodrigues ,&nbsp;Alexandra M. Gouveia","doi":"10.1016/j.arcmed.2025.103360","DOIUrl":"10.1016/j.arcmed.2025.103360","url":null,"abstract":"<div><h3>Background</h3><div>Mastectomy followed by breast reconstruction is the standard treatment for breast cancer. Choosing autologous tissue requires an in-depth understanding of the molecular and structural characteristics of the different adipose tissue depots.</div></div><div><h3>Method</h3><div>White adipose tissue (WAT) from five different locations (above and below the abdominal Scarpa’s fascia, thighs, breast skin envelope, and omentum) was collected from 24 patients undergoing breast reconstruction and grouped based on immediate (IBR) or delayed (DBR) reconstruction. The adipocyte area was analyzed in histologically processed WAT sections. Transcription and protein expression profiles, related to inflammation, fibrosis, browning, and adipose-derived stem cells (ADSCs) content were determined by RT-qPCR and Western blotting.</div></div><div><h3>Results</h3><div>Compared to IBR, omental WAT from DBR patients exhibits larger adipocytes, and higher expression of <em>TIMP1, FN1, CD206</em>, and <em>CD45</em>, as well as lower levels of <em>CIDEA</em>. Breast fat also differs between the two groups, with lower levels of <em>IL6</em> and <em>CIDEA,</em> and overexpression of <em>FN1</em> in the DBR group. Within the IBR group, breast fat shows higher levels of <em>IL6, TIMP1</em> and <em>CIDEA</em>, but lower expression of <em>FN1</em> and <em>COL3A1</em> than subcutaneous WAT.</div></div><div><h3>Conclusion</h3><div>Omental fat in the IBR cohort has properties similar to those of subcutaneous WAT, indicating that the omentum is a promising candidate for rapid breast restoration. In the DBR group, the omentum molecular signature suggests a change towards a pro-fibrotic phenotype and a reduced remodeling capacity, suggesting that it should not be the primary choice for breast reconstruction. This study emphasizes the importance of careful WAT selection to minimize adverse outcomes, including cancer recurrence, and underscores the diverse physiology of fat depots.</div></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103360"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145829242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Being the Chief Editor of a Scientific Journal 成为科学期刊的主编
IF 3.4 3区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2026-01-01 Epub Date: 2025-12-20 DOI: 10.1016/j.arcmed.2025.103370
Mardia López-Alarcón
{"title":"Being the Chief Editor of a Scientific Journal","authors":"Mardia López-Alarcón","doi":"10.1016/j.arcmed.2025.103370","DOIUrl":"10.1016/j.arcmed.2025.103370","url":null,"abstract":"","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"57 1","pages":"Article 103370"},"PeriodicalIF":3.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145796762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of Medical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1